Current NDC auxiliary source row compounder:281

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69194-130
Product Ndc: 69194-130
Product Ndc Digits: 69194130
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: 130 MOXIFLOXACIN IN BSS 150 MCG/0.1 ML
Proprietary Name Suffix: [empty]
Nonproprietary Name: MOXIFLOXACIN IN BSS
Dosage Form Name: INJECTION
Route Name: INTRAOCULAR
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Pine Pharmaceuticals LLC
Establishment Name: Pine Pharmaceuticals LLC
Establishment Fei: [empty]
Substance Name: MOXIFLOXACIN HYDROCHLORIDE
Active Ingredients Info: 150 ug/.1 mL
History Active Ingredients Raw: MOXIFLOXACIN HYDROCHLORIDE
History Active Ingredients Info Raw: 150 ug/.1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 69194-130-01
Package Ndc: 69194-130-01
Package Ndc Digits: 6919413001
Package Ndc11: 69194013001
Package Description: .5 mL in 1 VIAL (69194-130-01)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:281
Source Row Number: 281
Source Row Hash: 175c739c93a00a7a8985cc30005468f4b3602d62b3e81b5db680cbf61320800f
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAOCULAR",
    "PRODUCTNDC": "69194-130",
    "DEASCHEDULE": "",
    "LABELERNAME": "Pine Pharmaceuticals LLC",
    "SUBSTANCENAME": "MOXIFLOXACIN HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "69194-130-01",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "130 MOXIFLOXACIN IN BSS 150 MCG/0.1 ML",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "MOXIFLOXACIN IN BSS",
    "PACKAGEDESCRIPTION": ".5 mL in 1 VIAL (69194-130-01) ",
    "ACTIVEINGREDIENTSINFO": "150 ug/.1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:281
Source Row Number: 281
Status Scope: package
Lookup Ndc: 69194-130-01
Lookup Ndc Digits: 6919413001
Product Ndc: 69194-130
Product Ndc Digits: 69194130
Package Ndc: 69194-130-01
Package Ndc Digits: 6919413001
Package Ndc11: 69194013001
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 175c739c93a00a7a8985cc30005468f4b3602d62b3e81b5db680cbf61320800f
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20